What Is It to Be Human Anymore?
By Michael Hirsh,
Foreign Policy
| 04. 02. 2021
This book is not for the faint of mind. Walter Isaacson is a great storyteller who has devoted his justly acclaimed career as a biographer to such history-changing individuals as Albert Einstein, Steve Jobs, Henry Kissinger, and Leonardo da Vinci. Now, in his new book The Code-Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race, he tries to do the same with Jennifer Doudna, the engaging and brilliant University of California, Berkeley scientist who shared the 2020 Nobel Prize in chemistry with her French collaborator Emmanuelle Charpentier for discovering the inner workings of gene editing. Supported by a cast of eager and intensely competitive scientists who spanned the globe from Spain to China, Doudna and Charpentier figured out how to not only make human gene editing relatively simple but also turn it into what is, simultaneously, a hope-giving and terrifying technology.
As is typical for his work, Isaacson has done prodigious research—even learning to gene-edit himself. But perhaps his biggest challenge was that it may be easier to explain the achievements of da Vinci or even...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...